Apollo Hospitals Enterprise Limited vs Mylan Laboratories Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Mylan Laboratories Ltd (MATRIXLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs MATRIXLABS on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
0.00
13.46
P/B ratio
0.00
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹-26.11

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
-5.35%
17.31%
Return on capital
3.00%
14.94%
EBITDA margin
16.00%
7.94%
Net margin
-3.72%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
5.03%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹0 Cr
₹25,229 Cr
Revenue
₹10,969 Cr
₹2,003 Cr
Net profit
₹-408 Cr
0.90
Debt / equity
0.00
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Mylan Laboratories Ltd
  • − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 9.47% over past five years.", "Company has a low return on equity of -5.06% over last 3 years."]
Apollo Hospitals Enterprise Limited full analysis Mylan Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.